Detalhe da pesquisa
1.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411939
2.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671327
3.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
4.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355464
5.
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
JNCI Cancer Spectr
; 6(4)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877084
6.
Isolated appendicular tuberculosis.
J Ayub Med Coll Abbottabad
; 17(2): 88-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16092662
7.
Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
Int J Radiat Oncol Biol Phys
; 82(2): 1021-30, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21377280
8.
Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
Radiother Oncol
; 97(3): 418-24, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20826028